|

Prednisone/ prednisolone Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: Deltasone/Omnipred, Prednisolone

Pipeline

Phase 2: 1Phase 3: 2

Top Sponsors

  • Regeneron Pharmaceuticals1
  • Celgene1
  • AstraZeneca1

Indications

  • Cancer3
  • Follicular Lymphoma ( FL)1
  • Metastatic Castration-resistant Prostate Cancer1
  • Biliary Tract Cancer1
  • Endometrial Cancer1

Birmingham, Alabama1 trial

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

Local Institution - 0225

Phase 3

Tucson, Arizona1 trial

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

University of Arizona Cancer Center

Phase 3

Los Angeles, California1 trial

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.